Differences in Medical Mistrust Between Black and White Women: Implications for Patient–Provider Communication About PrEP
- 385 Downloads
Pre-exposure prophylaxis (PrEP) is an effective biomedical HIV prevention method. PrEP uptake has been persistently low among US women, particularly Black women, who account for 61% of new HIV diagnoses among women. Further understanding of barriers to Black women accessing PrEP is needed. This 2017 cross-sectional survey study explored race-based differences in PrEP interest and intention among women and the indirect association between race and comfort discussing PrEP with a healthcare provider through medical mistrust. The sample consisted of 501 adult women (241 Black; 260 White) who were HIV-negative, PrEP-inexperienced, and heterosexually active. Black women reported greater PrEP interest and intention than White women. However, Black women expressed higher levels of medical mistrust, which, in turn, was associated with lower comfort discussing PrEP with a provider. Medical mistrust may operate as a unique barrier to PrEP access among Black women who are interested in and could benefit from PrEP.
KeywordsBlack/African American Women Pre-exposure prophylaxis (PrEP) Medical mistrust HIV/AIDS
The authors are grateful to all individuals who participated in the present study. This study was funded by Yale Center for Interdisciplinary Research on AIDS (CIRA), which is funded by the National Institute of Mental Health under Award Number P30-MH062294. The efforts of S. K. Calabrese were supported by the NIMH via Award Number K01-MH103080. T. Taggart was supported by the NIMH via Award Number T32-MH02003 and the National Institute on Drug Abuse (NIDA) via the HIV/AIDS, Substance Abuse, and Trauma Training Program at the University of California, Los Angeles (R25-DA035692). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health, the National Institutes of Health, or Planned Parenthood Federation of America, Inc.
Compliance with Ethical Standards
Conflicts of interest
S. K. Calabrese has received compensation for her efforts in developing and delivering PrEP education materials. S. Hull receives honoraria for serving on the PrEP for Women Steering Committee for Gilead and has a subcontract with a Gilead-funded research study. The authors do not have other conflicts of interest to disclose.
All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individuals included in the study.
- 1.US Centers for Disease Control and Prevention. HIV/AIDS. 2018. Available from: https://www.cdc.gov/hiv/group/gender/women/.
- 2.US Census Bureau. Projections of the population by sex, hispanic origin, and race for the United States: 2015 to 2060. 2014.Google Scholar
- 8.Mera Giler R, Magnuson D, Trevor H, Bush S, Rawlings K, McCallister S. Changes in Truvada (TVD) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States: (2012–2016). In: 9th International AIDS Society Conference on HIV Science; Paris, France; 2017.Google Scholar
- 9.Siegler AJ, Mouhanna F, Mera Giler R, et al. The prevalence of PrEP use and the PrEP-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018; Advance online publication.Google Scholar
- 10.Bush S, Magnuson D, Rawlings MK, Hawkins T, McCallister S, Mera Giler R. Racial characteristics of FTC/TDF for pre-exposure prophylaxis (PrEP) users in the US. Boston: ASM Microbe; 2016.Google Scholar
- 11.Ball K, Lawson W, Alim T. Medical mistrust, conspiracy beliefs & HIV-related behavior among African Americans. J Psychol Behav Sci. 2013;1(1):1–7.Google Scholar
- 12.Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care. Smedley BD, Stith A, Nelson AR, editors. National Academies Press, Washington, DC; 2002.Google Scholar
- 13.Washington HA. Medical apartheid: the dark history of medical experimentation on Black Americans from colonial times to the present. Paw Prints. 2010.Google Scholar
- 34.Adams LM, Balderson BH, Brown K, Bush SE, Packett BJ. Who starts the conversation and who receives preexposure prophylaxis (PrEP)?: A brief online survey of medical providers’ PrEP practices. Health Educ Behav. 2018 (Advance Online Publication).Google Scholar
- 37.Dubov A, Altice FL, Fraenkel L. An information-motivation-behavioral skills model of PrEP uptake. AIDS Behav. 2018 (Advance Online Publication).Google Scholar
- 40.Connecticut Department of Public Health. Epidemiological profile of HIV Connecticut; 2016.Google Scholar
- 41.Connecticut Department of Public Health. CT Pre-exposure Prophylaxis (PrEP) Local Medical Services; 2017. Available from: https://portal.ct.gov/-/media/Departments-and-Agencies/DPH/dph/aids_and_chronic/prevention/pdf/PrEPServicespdf.pdf?la=en.
- 46.United States Department of Commerce Economics and Statistics Administration USCB. Race & Ethnicity; 2017. Available from: https://www.census.gov/mso/www/training/pdf/race-ethnicity-onepager.
- 47.Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. New York: Guilford Press; 2013.Google Scholar
- 56.Calabrese SK, Dovidio JF, Tekeste M, Taggart T, Galvao RW, Safon CB, Willie TC, Caldwell A, Kaplan C, Kershaw TS. HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend Planned Parenthood. J Acquir Immune Defic Syndr; 2018 (Advance Online Publication).Google Scholar
- 58.Mays VM, Mass RM, Ricks J, Cochran SD. HIV and African American women in the U.S. South: a social determinants approach to population level HIV prevention and Intervention efforts. In: Baum A, Revenson TA, Singer J, editors. Handbook of health psychology. 2nd ed. New York: Guilford; 2012. p. 771–802.Google Scholar